1-anilino-8-naphthalenesulfonate has been researched along with Progeria in 1 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
Progeria: An abnormal congenital condition, associated with defects in the LAMIN TYPE A gene, which is characterized by premature aging in children, where all the changes of cell senescence occur. It is manifested by premature graying; hair loss; hearing loss (DEAFNESS); cataracts (CATARACT); ARTHRITIS; OSTEOPOROSIS; DIABETES MELLITUS; atrophy of subcutaneous fat; skeletal hypoplasia; elevated urinary HYALURONIC ACID; and accelerated ATHEROSCLEROSIS. Many affected individuals develop malignant tumors, especially SARCOMA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Fukaishi, T | 1 |
Minami, I | 1 |
Masuda, S | 1 |
Miyachi, Y | 1 |
Tsujimoto, K | 1 |
Izumiyama, H | 1 |
Hashimoto, K | 1 |
Yoshida, M | 1 |
Takahashi, S | 1 |
Kashimada, K | 1 |
Morio, T | 1 |
Kosaki, K | 1 |
Maezawa, Y | 1 |
Yokote, K | 1 |
Yoshimoto, T | 1 |
Yamada, T | 1 |
1 other study available for 1-anilino-8-naphthalenesulfonate and Progeria
Article | Year |
---|---|
A case of generalized lipodystrophy-associated progeroid syndrome treated by leptin replacement with short and long-term monitoring of the metabolic and endocrine profiles.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Blood Glucose; Diabetes Mellitus; Dyslipid | 2020 |